ACTIVE

CELPHARMA

Financial year 2025 · closed on 31/12/2025
Net result
242,7 k €
Gross margin
635,6 k €
Equity
1,9 M €
Workforce
1,2 ETP

What does CELPHARMA do?

CELPHARMA is a Public limited company incorporated in 2025. Its main activity is: Manufacture of perfumes and toilet preparations. Its registered office is in Ixelles. It employs on average 1,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 1025.475.981
Incorporation
14/07/2025
Legal form
Public limited company
Registered office
Avenue Louise 503 box 9
1050 Ixelles · BruxellesSee on map
Contributed capital
1 003 110,35 €
Latest accounts
31/12/2025
Average workforce
1,2 ETP
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 1 financial year

2025
Income statement
Gross margin635,6 k €
EBITDA430 k €
Operating result364,6 k €
Net result242,7 k €
Balance sheet
Equity1,9 M €
Total assets3,8 M €
Debts1,9 M €
Other
Workforce1,2 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active

Active mandates

Antoine Carlhian

Director

Active
Gabriele Gavazzi

Director

Active
Laurent Ruessman

administrateur

Active
Think BVA

Administrateur · 0839.631.901

Represented by Bernard Van Acker

Active
Thomas Van Acker

administrateur

Active
At this address

Other companies at this address

CompanyCBE no.
0850.141.949
CROSS ET CABLEActive
0444.826.855
0465.130.440
Elena VromansActive
1035.310.593
0421.940.595
0438.410.108
LINGUEREActive
0457.415.475
RODIPAXActive
0437.539.086
Annual accounts

Full financial information

2025
Type of accountAbridged model
Start of the financial year01/01/2025
Closing of the financial year31/12/2025
Length of the financial year12 months
Filing date31/08/2026
General meeting09/05/2026
Currency of the financial yearEUR
NBB quality labelSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

1 filing with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202509/05/202631/08/2026FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active

Active mandates

Antoine Carlhian

Director

Active
Gabriele Gavazzi

Director

Active
Laurent Ruessman

administrateur

Active
Think BVA

Administrateur · 0839.631.901

Represented by Bernard Van Acker

Active
Thomas Van Acker

administrateur

Active
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates11/08/2025
    CAPITAL, ACTIONS, DEMISSIONS, NOMINATIONS
    PDF
  • Other22/07/2025
    Constitution CELPHARMA (suite à scission partielle TEONIA)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025242,7 k €
  2. 14/07/2025
    IncorporationPublic limited company